Insider Transactions in Q4 2022 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
653
-0.29%
|
$22,855
$35.33 P/Share
|
|
Nov 30
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
685
-0.16%
|
$23,290
$34.39 P/Share
|
|
Nov 16
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
342
-0.04%
|
$11,970
$35.89 P/Share
|
|
Nov 16
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,796
-0.4%
|
$62,860
$35.89 P/Share
|
|
Nov 16
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,306
-0.3%
|
$45,710
$35.89 P/Share
|
|
Nov 07
2022
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,723
+5.4%
|
-
|
|
Nov 07
2022
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Indirect |
220,816
+50.0%
|
-
|
|
Nov 07
2022
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
129,309
+23.03%
|
-
|
|
Nov 07
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
220,816
+50.0%
|
$8,611,824
$39.02 P/Share
|
|
Nov 07
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
566,171
+48.71%
|
$22,080,669
$39.02 P/Share
|
|
Nov 07
2022
|
Paul Kim CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
77,585
+25.57%
|
-
|
|
Nov 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,240
-0.83%
|
$45,880
$37.89 P/Share
|
|
Nov 03
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,198
-2.01%
|
$229,326
$37.89 P/Share
|
|
Nov 01
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
775
-0.25%
|
$31,000
$40.25 P/Share
|
|
Oct 30
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.01%
|
$3,040
$40.28 P/Share
|